{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:58:58Z","timestamp":1792198738247,"version":"4.4.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr. Treat. Options in Oncol."],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Opinion Statement<\/jats:title>\n                  <jats:p>Pain is one of the most prevalent and distressing symptoms in cancer, affecting up to 90% of patients and significantly impairing quality of life. Paracetamol (acetaminophen) and non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended by international guidelines for the management of non-surgical cancer pain, either alone or as adjuvants to opioids. In this paper, the current evidence for their efficacy, tolerability, and safety in this setting is reviewed. Evidence for paracetamol in cancer pain remains limited and of low quality. Small trials and systematic reviews suggest little or no additional analgesic benefit when used alongside strong opioids, and no clear advantage of intravenous over oral paracetamol has been demonstrated. Evidence for NSAIDs is slightly stronger, with studies indicating analgesic benefit both as monotherapy and in combination with opioids, although the quality of evidence is again restricted by small sample sizes, heterogeneity, and outdated trials. Concerns regarding adverse effects, particularly gastrointestinal, renal, and cardiovascular, often limit use, athough short-term use in patients receiving palliative care may be safer than historically perceived. Comparative data between individual NSAIDs, routes of administration, and longer-term use are lacking. Overall, while both paracetamol and NSAIDs are commonly prescribed and theoretically beneficial, high-quality, adequately powered studies in patients with cancer pain are scarce. Further research is needed to evidence their role, especially in opioid-sparing strategies, as well as determining the relative clinical effectiveness and harm of individual NSAIDs in patients with non-surgical cancer pain.<\/jats:p>","DOI":"10.1007\/s11864-025-01368-8","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T07:40:28Z","timestamp":1770882028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Paracetamol and NSAIDs in Cancer Pain Management: Evidence Review and Treatment Considerations"],"prefix":"10.1007","volume":"27","author":[{"given":"Kate","family":"Hanwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5272-3057","authenticated-orcid":false,"given":"Jason W","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"1368_CR1","unstructured":"International Agency For Research of Cancer. Cancer Tomorrow. 2022. https:\/\/gco.iarc.who.int\/tomorrow\/en\/dataviz\/bars?populations=903_904_905_908_909_935_900&years=2050"},{"key":"1368_CR2","doi-asserted-by":"crossref","unstructured":"Snijders RAH, Brom L, Theunissen M, van den Beuken-van Everdingen MHJ. Update on prevalence of pain in patients with cancer 2022: A systematic literature review and Meta-Analysis. Volume 15. Cancers. MDPI; 2023.","DOI":"10.3390\/cancers15030591"},{"key":"1368_CR3","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.3390\/curroncol30070500","volume":"30","author":"F Mestdagh","year":"2023","unstructured":"Mestdagh F, Steyaert A, Lavand\u2019homme P, Multidisciplinary Digital Publishing Institute (MDPI). Cancer pain management: a narrative review of current concepts, strategies, and techniques. Curr Oncol. 2023;30:6838\u201358.","journal-title":"Curr Oncol"},{"issue":"3","key":"1368_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00228-019-02801-2","volume":"76","author":"JW Boland","year":"2020","unstructured":"Boland JW, Allgar V, Boland EG, Bennett MI, Kaasa S, Hjermstad MJ, et al. The relationship between pain, analgesics and survival in patients with advanced cancer; a secondary data analysis of the international European palliative care cancer symptom study. Eur J Clin Pharmacol. 2020;76(3):393\u2013402.","journal-title":"Eur J Clin Pharmacol"},{"key":"1368_CR5","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, et al. Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol. 2018;29:iv166\u201391.","journal-title":"Ann Oncol"},{"issue":"3","key":"1368_CR6","first-page":"182","volume":"68","author":"BM Scarborough","year":"2018","unstructured":"Scarborough BM, Smith CB. Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018;68(3):182\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"1368_CR7","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.annonc.2022.08.083","volume":"33","author":"M Fallon","year":"2022","unstructured":"Fallon M, Dierberger K, Leng M, Hall PS, Allende S, Sabar R, et al. An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer. Ann Oncol. 2022;33(12):1296\u2013303.","journal-title":"Ann Oncol"},{"key":"1368_CR8","doi-asserted-by":"crossref","unstructured":"Pasternak GW. Preclinical Pharmacology and Opioid Combinations. Pain Medicine. 2012;13(SUPPL. 1).","DOI":"10.1111\/j.1526-4637.2012.01335.x"},{"issue":"4","key":"1368_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/0269216311428528","volume":"26","author":"M Nabal","year":"2012","unstructured":"Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A. The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO step III opioids in the control of pain in advanced cancer. A systematic review of the literature. Palliat Med. 2012;26(4):305\u201312.","journal-title":"Palliat Med"},{"key":"1368_CR10","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.2147\/JPR.S308028","volume":"14","author":"H Hoshijima","year":"2021","unstructured":"Hoshijima H, Hunt M, Nagasaka H, Yaksh T, Dove Medical Press Ltd. Systematic review of systemic and neuraxial effects of acetaminophen in preclinical models of nociceptive processing. J Pain Res. 2021;14:3521\u201352.","journal-title":"J Pain Res"},{"key":"1368_CR11","doi-asserted-by":"crossref","unstructured":"Chapman EJ, Edwards Z, Boland JW, Maddocks M, Fettes L, Malia C, et al. Practice review: evidence-based and effective management of pain in patients with advanced cancer, vol. 34. Palliative Medicine: SAGE Publications Ltd; 2020. p. 444\u201353.","DOI":"10.1177\/0269216319896955"},{"issue":"4","key":"1368_CR12","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/ejhpharm-2016-000952","volume":"23","author":"RA Moore","year":"2016","unstructured":"Moore RA, Moore N. Paracetamol and pain: the kiloton problem. Eur J Hosp Pharm. 2016;23(4):187\u20138.","journal-title":"Eur J Hosp Pharm"},{"key":"1368_CR13","doi-asserted-by":"crossref","unstructured":"Wiffen PJ, Derry S, Moore RA, Mcnicol ED, Bell RF, Carr DB et al. Oral paracetamol (acetaminophen) for cancer pain. Vol. 2017, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2017.","DOI":"10.1002\/14651858.CD012637"},{"issue":"2","key":"1368_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00045391-200007020-00009","volume":"7","author":"RC Dart","year":"2000","unstructured":"Dart RC, Kuffner EK, Rumack BH. Treatment of pain or fever with Paracetamol (acetaminophen) in the alcoholic patient: a systematic review. Am J Ther. 2000;7(2):123\u201334.","journal-title":"Am J Ther"},{"key":"1368_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2147\/JPR.S393809","volume":"16","author":"C Mallet","year":"2023","unstructured":"Mallet C, Desmeules J, Pegahi R, Eschalier A, Dove Medical Press Ltd. An updated review on the metabolite (AM404)-mediated central mechanism of action of paracetamol (acetaminophen): experimental evidence and potential clinical impact. J Pain Res. 2023;16:1081\u201394.","journal-title":"J Pain Res"},{"key":"1368_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.580289","author":"N Ohashi","year":"2020","unstructured":"Ohashi N, Kohno T, Frontiers Media S.A. Analgesic effect of acetaminophen: a review of known and novel mechanisms of action. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.580289.","journal-title":"Front Pharmacol"},{"key":"1368_CR17","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1002\/jcsm.12352","volume":"9","author":"RH Sch\u00fcchen","year":"2018","unstructured":"Sch\u00fcchen RH, M\u00fccke M, Marinova M, Kravchenko D, H\u00e4user W, Radbruch L, et al. Systematic review and meta-analysis on non-opioid analgesics in palliative medicine. J Cachexia Sarcopenia Muscle. 2018;9:1235\u201354.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"1368_CR18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.31083\/ph.2018.7878","volume":"73","author":"K Niki","year":"2018","unstructured":"Niki K, Okamoto Y, Nakajima S, Uejima E. The analgesic effect of rescue administration of intravenous acetaminophen in cancer patients may be associated with sex and opioid dose, and the effect would appear to patients administered under 45\u00a0mg\/day opioid (oral morphine equivalents). Pharmazie. 2018;73(3):161\u20134.","journal-title":"Pharmazie"},{"issue":"3","key":"1368_CR19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jpainsymman.2023.05.002","volume":"66","author":"O Leiva-V\u00e1squez","year":"2023","unstructured":"Leiva-V\u00e1squez O, Letelier LM, Rojas L, Viviani P, Castellano J, Gonz\u00e1lez A, et al. Is acetaminophen beneficial in patients with cancer pain who are on strong opioids? A randomized controlled trial. J Pain Symptom Manage. 2023;66(3):183\u2013e1921.","journal-title":"J Pain Symptom Manage"},{"issue":"3","key":"1368_CR20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.4212\/cjhp.v68i3.1458","volume":"68","author":"F Jibril","year":"2015","unstructured":"Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making. Can J Hosp Pharm. 2015;68(3):238\u201347.","journal-title":"Can J Hosp Pharm"},{"issue":"3","key":"1368_CR21","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/emermed-2017-206787","volume":"35","author":"J Furyk","year":"2018","unstructured":"Furyk J, Levas D, Close B, Laspina K, Fitzpatrick M, Robinson K, et al. Intravenous versus oral Paracetamol for acute pain in adults in the emergency department setting: A prospective, double-blind, double-dummy, randomised controlled trial. Emerg Med J. 2018;35(3):163\u20138.","journal-title":"Emerg Med J"},{"issue":"11","key":"1368_CR22","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1177\/0003134821989056","volume":"87","author":"DM Tompkins","year":"2021","unstructured":"Tompkins DM, DiPasquale A, Segovia M, Cohn SM. Review of intravenous acetaminophen for analgesia in the postoperative setting. Am Surg. 2021;87(11):1809\u201322.","journal-title":"Am Surg"},{"issue":"2","key":"1368_CR23","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ygyno.2020.11.024","volume":"160","author":"KE Cain","year":"2021","unstructured":"Cain KE, Iniesta MD, Fellman BM, Suki TS, Siverand A, Corzo C, et al. Effect of preoperative intravenous vs oral acetaminophen on postoperative opioid consumption in an enhanced recovery after surgery (ERAS) program in patients undergoing open gynecologic oncology surgery. Gynecol Oncol. 2021;160(2):464\u20138.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1368_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.drudis.2015.03.004","volume":"20","author":"AK Dwivedi","year":"2015","unstructured":"Dwivedi AK, Gurjar V, Kumar S, Singh N. Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs). Drug Discov Today. 2015;20(7):863\u201373.","journal-title":"Drug Discov Today"},{"key":"1368_CR25","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1016\/j.bja.2019.02.028","volume":"123","author":"DJ Magee","year":"2019","unstructured":"Magee DJ, Jhanji S, Poulogiannis G, Farquhar-Smith P, Brown MRD, Elsevier Ltd. Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. Br J Anaesth. 2019;123:e412-23.","journal-title":"Br J Anaesth"},{"issue":"11","key":"1368_CR26","first-page":"1705","volume":"37","author":"K Bonnesen","year":"2021","unstructured":"Bonnesen K, Schmidt M. Recategorization of non-aspirin nonsteroidal anti-inflammatory drugs according to clinical relevance: abandoning the traditional NSAID terminology. Can J Cardiol. 2021;37(11):1705\u20137.","journal-title":"Can J Cardiol"},{"issue":"2","key":"1368_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/14651858.CD012638.pub2","volume":"2020","author":"S Derry","year":"2017","unstructured":"Derry S, Wiffen PJ, Moore RA, McNicol ED, Bell RF, Carr DB, et al. Oral nonsteroidal anti-inflammatory drugs (NSAIDs) for cancer pain in adults. Cochrane Database Syst Rev. 2017;2020(2):12.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1368_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/02692163211045310","volume":"36","author":"B Butcher","year":"2022","unstructured":"Butcher B, Hutchings E, Fazekas B, Clark K, Rowett D, Currow D. Opioid-sparing effects of ketorolac in palliative care patients receiving opioids for chronic cancer-related pain: a systematic literature review. Palliat Med. 2022;36(1):71\u201380.","journal-title":"Palliat Med"},{"issue":"S3","key":"1368_CR29","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford LJ. Use of NSAIDs in treating patients with arthritis. Arthritis Res Ther. 2013;15(S3):S2.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1368_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1399-6576.1998.tb05083.x","volume":"42","author":"DMR Tram\u0155r","year":"1998","unstructured":"Tram\u0155r DMR, Williams JE, Carroll D, Wiffen PJ, Moore RA, McQuay HJ. Comparing analgesic efficacy of non-steroidal anti\u2010inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol Scand. 1998;42(1):71\u20139.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"1368_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"R Chou","year":"2016","unstructured":"Chou R, Gordon DB, De Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of postoperative pain: a clinical practice guideline from the American pain society, the American society of regional anesthesia and pain medicine, and the American society of anesthesiologists\u2019 committee on regional anesthesia, executive committee, and administrative council. J Pain. 2016;17(2):131\u201357.","journal-title":"J Pain"},{"issue":"3","key":"1368_CR32","volume":"14","author":"K Afshar","year":"2025","unstructured":"Afshar K, Gill J, Mostafa H, Noparast M. Nonsteroidal anti-inflammatory drugs (NSAIDs) for acute renal colic. Cochrane Database Syst Rev. 2025;14(3):CD006027.","journal-title":"Cochrane Database Syst Rev"},{"key":"1368_CR33","doi-asserted-by":"crossref","unstructured":"Derry S, Moore RA, Gaskell H, Mcintyre M, Wiffen PJ. Topical NSAIDs for acute musculoskeletal pain in adults. Vol. 2017, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2015.","DOI":"10.1002\/14651858.CD007402.pub3"},{"key":"1368_CR34","doi-asserted-by":"crossref","unstructured":"Derry S, Conaghan P, Da Silva JAP, Wiffen PJ, Moore RA. Topical NSAIDs for chronic musculoskeletal pain in adults. Vol. 2016, Cochrane Database of Systematic Reviews. John Wiley and Sons Ltd; 2016.","DOI":"10.1002\/14651858.CD007400.pub3"},{"issue":"2","key":"1368_CR35","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1310\/hpj5002-108","volume":"50","author":"ME Vacha","year":"2015","unstructured":"Vacha ME, Huang W, Mando-Vandrick J. The role of subcutaneous ketorolac for pain management. Hosp Pharm. 2015;50(2):108\u201312.","journal-title":"Hosp Pharm"},{"issue":"1","key":"1368_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1136\/bmjspcare-2017-001348","volume":"8","author":"P Armstrong","year":"2018","unstructured":"Armstrong P, Wilkinson P, McCorry NK. Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population. BMJ Support Palliat Care. 2018;8(1):25\u20139.","journal-title":"BMJ Support Palliat Care"},{"issue":"e1","key":"1368_CR37","doi-asserted-by":"publisher","first-page":"E55","DOI":"10.1136\/bmjspcare-2020-002792","volume":"13","author":"AJ Page","year":"2023","unstructured":"Page AJ, Mulvey MR, Bennett MI. Designing a clinical trial of non-steroidal anti-inflammatory drugs for cancer pain: a survey of UK palliative care physicians. BMJ Support Palliat Care. 2023;13(e1):E55\u20138.","journal-title":"BMJ Support Palliat Care"},{"key":"1368_CR38","doi-asserted-by":"crossref","unstructured":"Baigent C, Bhala N, Emberson J, Merhi A, Abramson S, Arber N, et al. Vascular and upper Gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769\u201379.","DOI":"10.1016\/S0140-6736(13)60900-9"},{"key":"1368_CR39","doi-asserted-by":"crossref","unstructured":"Dro\u017cd\u017cal S, Lechowicz K, Szostak B, Rosik J, Kotfis K, Machoy-Mokrzy\u0144ska A, et al. Kidney damage from nonsteroidal anti-inflammatory drugs\u2014Myth or truth? Pharmacology Research and Perspectives. Volume 9. John Wiley and Sons Inc; 2021.","DOI":"10.1002\/prp2.817"},{"issue":"e3","key":"1368_CR40","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1136\/spcare-2022-004154","volume":"13","author":"R McNeill","year":"2023","unstructured":"McNeill R, Boland JW, Wilcock A, Sinnarajah A, Currow DC. Non-steroidal anti-inflammatory drugs for pain in hospice\/palliative care: an international pharmacovigilance study. BMJ Support Palliat Care. 2023;13(e3):e1249\u201357.","journal-title":"BMJ Support Palliat Care"},{"key":"1368_CR41","unstructured":"Torpen LN. 2022. PARASTOP - Paracetamol with Strong Opioids in Moderate to Severe Cancer Pain. https:\/\/www.hra.nhs.uk\/planning-and-improving-research\/application-summaries\/research-summaries\/parastop-paracetamol-with-strong-opioids-in-moderate-to-severe-cancer-pain\/"}],"container-title":["Current Treatment Options in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11864-025-01368-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11864-025-01368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:08:19Z","timestamp":1781633299000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11864-025-01368-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s11864-025-01368-8","relation":{},"ISSN":["1527-2729","1534-6277"],"issn-type":[{"value":"1527-2729","type":"print"},{"value":"1534-6277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11"}}